- Home
- ATNM vs EPSM Comparison
ATNM vs EPSM Comparison
Compare ATNM & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATNM | EPSM |
|---|---|---|
| Founded | 2000 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 51.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ATNM | EPSM |
|---|---|---|
| Price | $1.57 | $2.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 224.5K | ★ 3.6M |
| Earning Date | 11-14-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $90,000.00 | ★ $8,446,963.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $42,943.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.11 | N/A |
| 52 Week Low | $1.03 | $1.31 |
| 52 Week High | $2.41 | $155.00 |
Technical Indicators
Market Signals| Indicator | ATNM | EPSM |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 31.57 |
| Support Level | $1.37 | $2.43 |
| Resistance Level | $1.54 | $4.00 |
| Average True Range (ATR) | 0.08 | 0.41 |
| MACD | 0.02 | 0.63 |
| Stochastic Oscillator | 72.97 | 9.95 |
Price Performance
Historical ComparisonAbout ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.